Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2006-07-25
2006-07-25
Weber, Jon (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S300000, C530S330000, C424S059000
Reexamination Certificate
active
07081442
ABSTRACT:
The present invention relates to compositions containing a peptide(s) and a pigment(s) and the use thereof in darkening the skin.
REFERENCES:
patent: 3755560 (1973-08-01), Dickert et al.
patent: 4254105 (1981-03-01), Fukuda
patent: 4421769 (1983-12-01), Dixon et al.
patent: 4453941 (1984-06-01), Jacobs
patent: 4960764 (1990-10-01), Figueroa, Jr. et al.
patent: 5216116 (1993-06-01), Pawelek
patent: 5218079 (1993-06-01), Pawelek et al.
patent: 5225435 (1993-07-01), Pawelek et al.
patent: 5227459 (1993-07-01), Pawelek et al.
patent: 5260065 (1993-11-01), Mathur et al.
patent: 5384116 (1995-01-01), Pawelek et al.
patent: 5618519 (1997-04-01), Pawelek et al.
patent: 5698184 (1997-12-01), Pickett
patent: 5744125 (1998-04-01), Pawelek et al.
patent: 5763575 (1998-06-01), Sundelin et al.
patent: 6323219 (2001-11-01), Costanzo
patent: 2002/0197219 (2002-12-01), Seiberg et al.
patent: 0 273 202 (1995-06-01), None
patent: WO 96/31194 (1996-04-01), None
patent: WO 99/37279 (1998-11-01), None
patent: WO 00/15188 (2000-03-01), None
patent: WO 00/62743 (2000-10-01), None
John A. Wenninger, G.N. McEwen, Jr.,International Cosmetic Ingredient Dictionary and Handbook, (1997), 1612-1613, 1626, 1654-1661, 1673-1686, 1693-1697,Seventh Edition 1997, vol. 2, The Cosmetic, Toiletry, and Fragrance Association, Washington, DC.
Miklos Bodanszky, In Search of new methods in peptide synthesis, (1985) 449-474, International J. Peptide Protein Research 25, Munksgaard International Pubblishers Ltd. Copenhagen Denmark.
Michael Mezei, Vijeyalakshmi Gulasekharam, Liposomes-A selective drug delivery system for the topical route of administration: gel dosage form, (1982) Journal Pharm. Pharacol. 34:473-474.
Susan M. Niemiec, Chandrasekharan Ramachandran, Norman Weiner, Influence of Nonionic Liposomal Composition on Topical Delivery of Peptide Drugs into Pilosebaceous Units: An in Vivo Study Using the Hamster Ear Model, (1995), Pharmaceutical Research, vol. 12, No. 8:1184-1188, Plenum Publishing Corporation.
Petra Boukamp, Rule T. Petrussevska, Dirk Breitkreutz, Jurgen Hornung, Alex Markham, Norbert E. Fusenig, Normal Keratinization in a Spontaneously Immortalized Aneuploid Human Keratinocyte Cell Line, (1988), The Journal of Cell Biology, vol. 106:761-771, The Rockefeller University Press.
M. Seiberg, C. Paine, E. Sharlow, P. Andrade-Gordon, M. Costanzo, M. Eisinger, S. S. Shapiro, The Protease-Activated Receptor 2 Regulates Pigmentation via Keratinocyte-Melanocyte Interactions, (2000), Experimental Cell Research, 25-32, Academic Press.
E.R. Sharlow, C.S. Paine, L. Babiarz, M. Eisinger, S. Shapiro, M. Seiberg, The protease-activated receptor-2 upregulates keratinocyte phagocytosis, (2000)Journal of Cell Science 113:3093-3101, The Company of Biologists Limited.
Miri Seiberg, Christine Paine, Elizabeth Sharlow, Patricia Andrade-Gordon, Michael Constanzo, Magdalena Eisinger and Stanley S. Shapiro, Inhibition of Melanosome Transfer Results in Skin Lightening, (2000), The Journal of Investigative Dermatology, vol. 115, No.2:162-167, The Society of Investigative Dermatology, Inc.
Dezna C. Sheehan, Barbara B. Hrapchak, Theory and practice of Histotechnology, (1980), 223,224,277 Second Edition, Battle Press.
D.D. Breimer, P. Speiser, Liposomes as a Skin Drug Delivery System, Topics in Pharmaceutical Sciences (1985), Elsevier Science Publishers, New York, pp. 345-358.
McCutcheon's Emulsifiers & Detergents, 1986 North American Edition, pp. 317-324.
Cosmetics Science and Technology, 1972 John Wiley & Sons, Inc. Canada, pp. 32-43, 72-73, 443-465.
Johnson & Johnson Consumer Companies, Inc., Pending U.S. Appl. No. 09/862,145.
Johnson & Johnson Consumer Companies, Inc., Pending U.S. Appl. No. 09/861,972.
Chemical Abstracts, vol. 127, No. 16, 1997 Columbus, Ohio, US, abstract No. 218497e, S. Tajima et al.; “Modulation by elastin peptide VGVAPG of cell proliferation and elastin expression in human skin fibroblasts” XP002231281 & Arch. Dermatol Res., vol. 289, No. 8, 1997 pp. 489-492.
PCT International Search Report dated Nov. 5, 2003 for corresponding PCT application US02/16713.
Seiberg Miri
Shapiro Stanley S.
Johnson & Johnson Consumer Companies Inc.
Teller Roy
Weber Jon
LandOfFree
Composition containing a peptide and a pigment and the use... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Composition containing a peptide and a pigment and the use..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition containing a peptide and a pigment and the use... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3530400